Valneva SE (VLA) | Financial Analysis & Statements

Valneva SE | Mid-cap | Healthcare

€2.43

1.84%

Valneva SE vs Medincell S.A Valneva SE vs BNP Paribas Easy Valneva SE vs Abivax SA Valneva SE vs Inventiva S.A Valneva SE vs Viridian Valneva SE vs CAC 40 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 169.6M

Gross Profit 71.0M 41.89%

Operating Income -77.8M -45.86%

Net Income -12.2M -7.22%

EPS (Diluted) -€0.08

Balance Sheet Metrics

Total Assets 500.0M

Total Liabilities 318.8M

Shareholders Equity 181.3M

Debt to Equity 1.76

Cash Flow Metrics

Operating Cash Flow 30.3M

Free Cash Flow -83.7M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Valneva SE Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	169.6M	153.7M	361.3M	348.1M	110.3M
Cost of Goods Sold	98.5M	100.9M	324.4M	187.9M	54.3M
Gross Profit	71.0M	52.8M	36.9M	160.2M	56.0M
Operating Expenses	148.5M	134.5M	150.0M	221.3M	111.1M
Operating Income	-77.8M	-82.1M	-113.4M	-61.3M	-55.1M
Pre-tax Income	-11.5M	-98.6M	-144.8M	-70.0M	-65.3M
Income Tax	761.0K	2.8M	-1.5M	3.4M	-909.0K
Net Income	-12.2M	-101.4M	-143.3M	-73.4M	-64.4M
EPS (Diluted)	-€0.08	-€0.73	-€1.24	-€0.75	-€0.71

Income Statement Trend

Valneva SE Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	299.0M	262.8M	424.7M	585.8M	308.4M
Non-Current Assets	201.0M	197.2M	196.7M	231.5M	140.7M
Total Assets	500.0M	460.1M	621.3M	817.4M	449.2M
Liabilities
Current Liabilities	114.6M	158.9M	277.4M	369.0M	175.9M
Non-Current Liabilities	204.2M	173.0M	124.2M	277.8M	195.9M
Total Liabilities	318.8M	331.8M	401.5M	646.8M	371.7M
Equity
Total Shareholders Equity	181.3M	128.2M	219.8M	170.6M	77.4M

Balance Sheet Composition

Valneva SE Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-12.2M	-101.4M	-143.3M	-73.4M	-64.4M
Operating Cash Flow	30.3M	-182.3M	-231.5M	24.2M	123.3M
Investing Activities
Capital Expenditures	-13.7M	-14.1M	-29.2M	-92.2M	-18.9M
Investing Cash Flow	77.1M	-21.7M	-29.2M	-92.2M	-18.9M
Financing Activities
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-6.5M	75.6M	224.3M	162.9M	26.5M
Free Cash Flow	-83.7M	-217.1M	-274.7M	-16.3M	118.3M

Cash Flow Trend

Valneva SE Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 70.64

Forward P/E -6.51

Price to Book 2.11

Price to Sales 2.20

PEG Ratio -6.51

Profitability Ratios

Profit Margin -43.21%

Operating Margin -12.11%

Return on Equity -44.11%

Return on Assets -19.19%

Financial Health

Current Ratio 2.70

Debt to Equity 120.48

Beta 1.09

Per Share Data

EPS (TTM) -€0.57

Book Value per Share €1.14

Revenue per Share €1.25

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
vla	409.5M	70.64	2.11	-44.11%	-43.21%	120.48
Medincell S.A	565.5M	-18.81	-	61.33%	-66.50%	-1.44
BNP Paribas Easy	456.7M	15.91	-	-96.39%	-27.22%	2.22
Abivax SA	331.7M	-1.96	-52.78	-196.12%	0.00%	-16.16
Inventiva S.A	379.0M	-0.88	-0.99	172.73%	0.00%	-1.70
Viridian	415.4M	50.43	0.40	0.93%	2.05%	103.04

Financial data is updated regularly. All figures are in the company's reporting currency.